New York, New York (PRWEB) April 01, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, has submitted an application requesting that the Superior Court of New Jersey reconsider its previous decision denying the Defendant Bayer’s application for Centralized Management of Multicounty Litigation for Mirena IUD lawsuits. The application, dated March 6, 2013, was submitted to the Honorable Glenn A. Grant, J.A.D. by Senior Litigation Counsel Matthew J. McCauley and attorney Jessica Vertullo of Parker Waichman LLP. The application was entitled Re: Application Pursuant to R. 4:38A (“Centralized Management of Multicounty Litigation”) Joint Request for Reconsideration of Designation of Mirena® litigation as a Multicounty Litigation for Centralized Management.
According to the application, on January 2, 2013 the Court denied Bayer’s application to centralize Mirena IUD lawsuits into a multicounty litigation. Parker Waichman LLP has requested that the court reconsider this decision based on the fact that there are now more than 60 lawsuits alleging injuries from this contraceptive device; on its own, Parker Waichman LLP has already filed 50 cases in Morris County. The application noted that both parties for the Defendants and the Plaintiffs are in support of this motion.
The application states that centralization of all Mirena cases and designation as a multicounty litigation is warranted for several reasons. Firstly, the Mirena IUD litigation involves a large number of parties that are widely dispersed across the state and country. Currently, the cases filed by Parker Waichman LLP in New Jersey represent Plaintiffs at least 23 different states. Secondly, the Mirena IUD cases involve common questions of fact associated with the product. The lawsuits share similar allegations and as well as alleged injuries, such as uterine perforation and device embedment. Lastly, the firm expects that numerous additional and similar lawsuits regarding the Mirena IUD will be filed; centralization will allow litigation to move forward with greater efficiency, the application states.
Matthew J. McCauley also co-chairs the American Association for Justice (AAJ) Mirena® IUD Litigation Group. The Group is actively involved in exchanging educational materials and medical literature in order to best represent victims.
Bayer’s Mirena IUD was approved in 2000. The product is a small, t-shaped plastic device attached to two strings; a hormonal IUD, it releases levonorgestrel when placed in the uterus to prevent pregnancy. Mirena is inserted and removed by a healthcare professional. It can be left in the uterus for up to five years. According to the U.S. Food and Drug Administration (FDA), the most serious side effects associated with the Mirena® IUD include:
- Perforation of the uterine wall
- Embedment of the device in the uterine wall
- Intrauterine pregnancy
- Ectopic pregnancy
- Group A streptococcal sepsis
- Pelvic inflammatory disease (PID)
Parker Waichman LLP continues to offer free lawsuit consultations to victims of Mirena® IUD birth control. If you or as a loved one experienced complications following the use of this device, please visit the firm's Mirena® IUD Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney